Australia markets closed

PGNY Nov 2021 55.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.3000+0.4000 (+13.79%)
As of 3:55PM EDT. Market open.
Full screen
Previous close2.9000
Open2.4500
Bid2.6000
Ask3.6000
Strike55.00
Expiry date2021-11-19
Day's range2.4500 - 3.3000
Contract rangeN/A
Volume136
Open interest356
  • Motley Fool

    3 Innovative Growth Stocks That'll Make You Richer Through 2025

    When you're investing in growth stocks, especially in the healthcare space, you might be willing to accept a company's unprofitability for a period of time, provided its revenue is increasing. All three companies I'm about to discuss are profitably making products that are substantially better than the mainstream standards in their fields. For complex and serious wounds, however, they might be better served by one of the advanced wound care products made by Organogenesis Holdings (NASDAQ: ORGO).

  • Simply Wall St.

    Progyny (NASDAQ:PGNY) shareholder returns have been solid, earning 122% in 1 year

    Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really...

  • GlobeNewswire

    Progyny, Inc. to Present at the BofA Global Healthcare Conference

    NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the BofA Global Healthcare Conference on Wednesday, September 15, 2021 at 10:55 A.M. Eastern Time, or 3:55 P.M. British Summer Time. A live au